Help and Resources

Here, you'll find lots of resources to help you whether you're a patient, carer, fundraiser or medical professional.

Know your rights toolkit

We have produced a number of bitesize pieces of information to help you understand the options that are available to you, access further information and make informed decisions.

Information Booklets

Learn more about your diagnosis in our information booklets.

Leukaemia Matters magazine

Leukaemia Matters is a patient magazine published four times a year. You can subscribe to Leukaemia Matters for free by going to the request a resource page.

Fundraising Resources

Get your fundraising off to a flying start with our selection of downloadable materials.

Our reports

Our reports are based on the findings from our surveys and are written with the patient in mind.

Request a Resource

To order printed information, please select the number of each resource you require, and fill in your contact details. Unfortunately, we are unable to send printed information overseas.

T-cell Acute Lymphoblastic Leukaemia

T-cell acute lymphoblastic leukaemia (T-ALL) is a specific type of leukaemia. It is a variant of acute lymphoblastic leukaemia (ALL), with features similar to some types of lymphoma.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

September 18th

CVs – a how-to guide

In our second blog on getting back to work, we look at CVs, their uses, and how to write one....

September 16th

Blood Cancer Awareness Month so far

We’re halfway through Blood Cancer Awareness Month and our Spot Leukaemia campaign. Here, we round up the campaign so far....

September 7th

The Scottish Medicine Consortium (SMC) approves gilteritinib for relapsed/refractory AML patients in Scotland

The Scottish Medicine Consortium (SMC) has recommended the use of gilteritinib for patients who have relapsed or refractory acute myeloid leukaemia (AML) with a FLT3 mutation. Find out what this means for patients in Scotland here....